Pope Francis, not Pope Leo XIV, has received positive news regarding his recovery from a recent health issue. According to medical updates, further treatment for lung cancer will not be necessary, as tests have confirmed that the tumor removed was localized and contained.
Doctors Dr. Luigi Carbone and Stefano Margaritora, who are treating the individual, released a statement through the Vatican, detailing the latest developments in the patient's condition.
Papal medical tests revealed the presence of a localized pulmonary adenocarcinoma, a form of cancer, following the medical intervention.
A follow-up medical evaluation has confirmed that no further treatment is necessary.
The latest development has brought a sense of relief to the faithful and those closely monitoring the health of Pope, who has started to gradually resume his public engagements.
A tumor was unexpectedly identified during a routine medical examination.
Doctors discovered a small discoloration at the base of the lung during a medical examination.
The Holy Father falls into the category of individuals who unexpectedly discover they have lung cancer.
A surgical procedure was performed on October 13, lasting approximately 90 minutes, to remove the lower lobe of the patient's right lung.
The patient departed Gemelli Hospital in Rome on Saturday, October 17, and subsequently returned to the Vatican four days after his initial hospitalization.
Pope Leo XIV expressed gratitude to those who offered their affection and prayers during his recent hospital stay.
The experience has strengthened his connection to individuals living with various health conditions or disabilities.
The individual expressed confidence in gradually resuming his obligations, taking into account the significance of his ongoing recovery process.
Pope Francis led his weekly general audience in St. Peter's Square on Wednesday, October 21, where he welcomed the faithful and offered blessings to children approaching him.
The Vatican has announced plans for a diplomatic visit to South America, scheduled to take place from November 6 to 17. The trip will include stops in Uruguay, Argentina, and Peru.
A favorable medical outcome does not preclude the need for continued clinical follow-up, even in the absence of additional treatment.
